Added to YB: 2024-06-19
Pitch date: 2024-06-18
HIMS [bullish]
Hims & Hers Health, Inc.
-17.02%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$24.50
Price Target
56.00 (+175%)
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
value
Hims & Hers: The Undervalued Gem Poised For Growth
HIMS: Online healthcare platform. Q1 subs +41% YoY to 1.7M, rev +46% to $278M. Adding personalized products driving retention. GLP-1 alternative to Ozempic/Wegovy at <$199/mo amid shortages & rising obesity. PT $56 on 25x P/E of $650M 2028e net income (20% margin on $3.2B rev), 187% upside. Risks: GLP-1 availability, CEO controversy.
Read full article (5 min)